Product NDC: | 35356-252 |
Proprietary Name: | MAXALT |
Non Proprietary Name: | rizatriptan benzoate |
Active Ingredient(s): | 10 mg/1 & nbsp; rizatriptan benzoate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 35356-252 |
Labeler Name: | Lake Erie Medical DBA Quality Care Products LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020864 |
Marketing Category: | NDA |
Start Marketing Date: | 20070824 |
Package NDC: | 35356-252-18 |
Package Description: | 18 POUCH in 1 CARTON (35356-252-18) > 1 TABLET in 1 POUCH |
NDC Code | 35356-252-18 |
Proprietary Name | MAXALT |
Package Description | 18 POUCH in 1 CARTON (35356-252-18) > 1 TABLET in 1 POUCH |
Product NDC | 35356-252 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rizatriptan benzoate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20070824 |
Marketing Category Name | NDA |
Labeler Name | Lake Erie Medical DBA Quality Care Products LLC |
Substance Name | RIZATRIPTAN BENZOATE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |